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Background: The respiratory related target motion and setup error will lead to a large margin in the gastric
radiotherapy. The purpose of this study is to investigate the dosimetric benefit and the possibility of incorporating
the breath-hold (BH) technique with online image-guided radiotherapy in the adjuvant gastric cancer radiotherapy.
Methods: Setup errors and target motions of 22 post-operative gastric cancer patients with surgical clips were
analyzed. Clips movement was recorded using the digital fluoroscopics and the probability distribution functions
(pdf) of the target motions were created for both the free breathing (FB) and BH treatment. For dosimetric
comparisons, two intensity-modulated radiotherapy (IMRT) treatment plans, i.e. the free breathing treatment plan
(IMRTFB) and the image-guided BH treatment plan (IMRTIGBH) using the same beam parameters were performed
among 6 randomly selected patients. Different margins for FB and BH plans were derived. The plan dose map was
convoluted with various pdfs of the setup errors and the target motions. Target coverage and dose to organs at
risk were compared and the dose-escalation probability was assessed.
Results: The mean setup errors were 1.2 mm in the superior-inferior (SI), 0.0 mm in the left-right (LR), and 1.4 mm
in the anterior-posterior (AP) directions. The mean target motion for the free breathing (vs. BH) was 11.1 mm (vs.
2.2 mm), 1.9 mm (vs. 1.1 mm), and 5.5 mm (vs. 1.7 mm) in the SI, LR, and AP direction, respectively. The target
coverage was comparable for all the original plans. IMRTIGBH showed lower dose to the liver compared with IMRTFB
(p = 0.01) but no significant difference in the kidneys. Convolved IMRTIGBH showed better sparing in kidneys
(p< 0.01) and similar in liver (p = 0.08).
Conclusions: Combining BH technique with online image guided IMRT can minimize the organ motion and
improve the setup accuracy. The dosimetric comparison showed the dose could be escalated to 54 Gy without
increasing the critical organs toxicities, although further clinical data is needed.
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The gastric carcinoma is one of the leading causes of can-
cer death in China. Traditionally, radiation therapy has
played a limited role in the management of gastric tumors
[1]. The Southwest Oncology Group study INT0116
showed that the adjuvant chemotherapy with concurrent
radiation had significant benefit in overall survival* Correspondence: zhenzhang6@yahoo.com
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reproduction in any medium, provided the orcompared to surgery alone, however, the acute toxicity
was high mainly due to the AP/PA field arrangement used
in the radiation treatment [2]. Compared with the tech-
nique used in the INT-0116 study, the 3D conformal
radiotherapy (3DCRT) and intensity modulated radiation
therapy (IMRT) can largely reduce the dose to the sur-
rounding dose-limiting structures such as liver and kid-
neys [3,4]. However, even with these advanced treatment
techniques, a large margin is still needed to account for
the setup uncertainties and the target motions. This limits
the dose that can be safely delivered to the target and po-
tential dose escalation in gastric cancer radiation.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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daily image guidance correction [5]. However, the re-
spiratory related target motions are of major concerns
for abdominal tumors. Data from 4D CT and fluoros-
copy have shown that the organs and tumors in the ab-
dominal region can move 10–27 mm in a normal
breathing cycle [6]. Various methods have been pro-
posed to reduce the respiratory induced target motion,
such as the active or passive breath-hold techniques, ab-
dominal compression, respiratory gating and tracking [7-
9]. The active breathing control (ABC) is one of breath-
hold (BH) methods, which can reduce the target motion
by temporarily suspending the patient’s breath during
the treatment delivery.
The static dose can be convoluted with the probabil-
ity distribution functions (pdf ) of the motion for in-
corporating the motion to obtain a really dose
distribution. Such method has been used to investigate
the motion effect in many sites such as liver and pan-
creas [10,11]. But, the impact of target motion on the
IMRT and the dosimetric benefit of combining breath-
hold technique with the image guidance in the gastric
cancer radiotherapy have not been reported. The pur-
poses of this study are to 1) quantify the target motion
in the gastric cancer treatment with or without the
breath-hold technique, 2) evaluate the effect of the
setup uncertainties and target motion on the planned
dose, 3) assess the possibility of dose escalation with
image guided breath-hold IMRT.Methods
Patient selection and CT imaging
Twenty-two patients diagnosed with T3-4 and/or N+,
staging II-IV gastric cancer and received post-
operative radiation therapy between July and Decem-
ber 2008 were enrolled in the study. The study was
reviewed and approved by the institutional ethics
committee. Four to six surgical clips used as target-
motion surrogates were implanted near the tumor bed
during the surgery prior to the radiotherapy. Custo-
mized vacuum lock bags (Med-Tec Corporation, USA)
were used for patient immobilization. Each patient
went through an ABC (Elekta Oncology Systems,
Crawley, UK) training session with an experienced
therapist during the simulation.
The planning CT images were acquired in 5-mm slice
thickness on a large bore CT scanner (Philips Medical
Madison, WI) with ABC. The volume threshold for
breath hold was set to 75% of the deep inspiration. A ra-
diation oncologist delineated the clinical target volumes
(CTVs) and critical structures such as liver, kidneys and
spinal cord. The CTV included the tumor bed and the
regions of lymphatic drainage.Setup error and target motion
The setup error and target motion were evaluated by
weekly digital fluoroscopic imaging throughout the treat-
ment course. Patient setup was mimicked on a simulator
(Ximatron, Varian Medical) weekly by two therapists who
actually positioned the patient on the treatment machine
everyday. For the free breathing (FB) treatment, the pa-
tient was instructed to breathe normally. Several series of
the anterior-posterior and lateral orthogonal fluoroscopic
images were acquired to cover several breathing cycles
after the patient had established a stable and reproducible
breathing pattern. For the breath-hold (BH) treatment,
patients were instructed to hold their breath with the aid
of ABC and 3–4 consecutive series of fluoroscopic im-
aging were acquired for each patient with two-minute
intervals during each simulation session.
The fluoroscopic images were registered to the digit-
ally reconstructed radiography (DRR) images generated
by the treatment planning system (TPS, Philips Medical
Systems, Pinnacle v7.6c, Milpitas, CA) based on the ver-
tebral column. As the patients were initially set up to
the skin marks, the setup errors were derived from the
registration shifts ignoring the rotation errors. Addition-
ally, the clips on each frame of the images were traced
and recorded to calculate the trajectory of the target mo-
tion under FB mode, or the residual motion for the BH
mode, assuming the target-motion related clip deform-
ation was negligible.
The centroid location of the clips representing the target
motion was calculated on each frame. The fluoroscopic
images were captured at a rate of 3 frames per second.
Probability distribution function
The displacement of the centroid was plotted against the
time (the amplitude of the target motion versus time),
which could be converted to the probability distribution
function (pdf ) of the target motion (probability versus
position). A pdf was derived from the weekly orthogonal
fluoroscopic images and used to calculate the accumula-
tive dose that the patient received for that week.
Dose comparison and escalation
The setup error can be regarded as independent of the tar-
get motion during the treatment delivery, thus the quad-
ratic model was used to estimate the CTV to planning
target volume (PTV) margin for treatment planning. This
total margin consists of the setup margin (SM) and the in-





PTVs (PTVFB and PTVIGBH) were generated from the
same CTV for each patient using different margins: treat-
ment delivery in the FB condition without image guidance
(“FB” scenario) and treatment delivery with online image-
guided BH condition (“IGBH” scenario). Note that the
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and target motion data collected from twenty-two
patients. For each patient, two plans (IMRTFB for PTVFB
and IMRTIGBH for PTVIGBH) were generated with 7–9 co-
planar fields and maximum 35–45 segments, and the same
dose prescription, beam orientation and objective func-
tions were used in the optimization. The prescription was
45 Gy delivered in 25 fractions. The final treatment plans
should meet the following criteria: at least 95% of PTV
(PTVFB and PTVIGBH) received 45 Gy and ≥99% of PTV
received 42.75 Gy; less than 30% of the liver received
26 Gy; no more than 33% of any kidney received ≥18 Gy;
and the spinal cord dose ≤45 Gy. The final dose matrices
were exported to program ImageJ (NIH, http://rsbweb.nih.
gov/ij/) for 3D convolution calculations.
The details were listed as following:
(1)Extract the 3D dose matrix for five fractions of
treatment from the original treatment plans
(IMRTFB and IMRTIGBH) in the Pinnacle PlanningFigure 1 The diaphragm of this study.System. The 3D dose matrix was recorded as 32-bit
real numbers in big endian format.
(2)Read this 3D dose matrix for five fractions in Image
J program. The 3D dose matrix was expressed as a
stack of 2D transverse dose planes in Image J;
(3)Import the weekly pdfs in the Image J. The weekly
pdf was the probabilities of the target at each
position along three directions, AP, LR and SI, for
five fractions of treatment;
(4)Convolute the 3D dose matrix with the weekly pdfs
using the “Convolution 3D” function in Image J
program. For the free breathing scenario, the static
weekly dose matrix from the original static IMRTFB
plan was convoluted with the pdfs for the setup
errors (pdfSetupFB) and for the free breathing target
motion (pdfFB) derived from the weekly fluoroscopic
imaging; and for the image-guided breath hold
scenario, the static weekly dose matrix of the
IMRTIGBH plan was convoluted with the weekly pdf
of the residual target motion for multiple breath
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image guidance (pdfSetupBH).
(5)Pinnacle scripts were written to import the motion
incorporated dose distribution (result of last step)
for analysis and evaluation.
The target coverage and dose to organs at risk for both
scenarios were compared using the two-sided Wilcoxon
matched-pair signed-rank test. It was considered statisti-
cally significant if p ≤ 0.05. Additionally, the prescription
dose was increased from 45 Gy to 54 Gy in the
IMRTIGBH plans to investigate the probability of dose es-
calation. Figure 1 shows the scheme of this study.Results
Setup uncertainties
A total of 220 pairs of orthogonal fluoroscopic images
were acquired for the 22 patients. The mean (simple
average) and stand deviation of the setup variations
along the superior-inferior (SI), left-right (LR) and
anterior-posterior (AP) directions are 1.2 ± 3.4 mm,
0.0 ± 1.8 mm, and −1.4 ± 3.1 mm, respectively. The mar-
gin for setup error (MSetup) is 8.3 mm in the SI direction,
3.3 mm in the LR direction, and 6.4 mm in the AP dir-
ection calculated with the margin recipe proposed by
Van Herk, et al. [12].Figure 2 The clips motion trajectory after their positions on each fram
LR direction) and the displacement of the centroid clips versus time i
Functions In The Si, Lr And Ap Direction For The Free Breathing TreaTarget motion
Free breathing scenario
Figure 2.A and B depict the motion trajectory of the
clips on the AP and LR views in the free breathing con-
dition for one patient (Patient5). In this figure 20 frames
of the fluoroscopic images were projected to a reference
frame (the end of inspiration image). The target motion
was represented by the motion of the centroid of clips,
assuming that the relative positions between any two
clips did not change significantly. The displacement of
the centroid versus the time for one breathing cycle
along the AP, LR and SI directions for this patient is illu-
strated in Figure 2.C. The mean values of the motion ex-
cursion are 11.1, 1.9, and 5.5 mm in the SI, LR, and AP
direction, respectively. The margin to compensate for
the target motion in free breathing, calculated as MFB =
Mean +3SD, is 20.4 mm in the SI direction, 4.9 mm in
the LR direction, and 13.0 mm in the AP direction to
ensure that 99.7% of the times the target falls within this
margin.Breath-hold scenario
The maximum residual target motion in the SI, LR and
AP directions are 10.1 mm, 3.5 mm and 8.1 mm, re-
spectively. The mean values of the motion excursion are
3.7, 1.6, and 2.8 mm in the SI, LR, and AP direction,e were projected on to the reference frame (A: AP direction; B:
n SI, LR, and AP directions (C). D: Weekly Probability Distribution
tment.
Table 1 The range, mean and standard deviation (SD) of
the target motion represented by the movement of the
centroid of the clips in free breathing and breath-hold
conditions
SI(mm) LR (mm) AP (mm)
Free breathing Max 20.0 5.8 12.5
Min 2.8 0.8 2.2
Mean 11.1 1.9 5.5
SD 3.1 1.0 2.5
Margin 20.4 4.9 13.0
Breath hold Max 10.1 3.5 8.1
Min 1.0 0.3 0.8
Mean 3.7 1.6 2.8
SD 2.0 0.8 1.7
Margin 9.7 5.0 7.9
The margin for target motion was calculated using three times of the SD. All
data are calculated from the entire group of the patients.
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less than 6 mm is 86.1% in SI, 91.4% in AP and 100% in
the LR direction. Based on the formula MBH=Mean
+3SD, a margin of 9.7 mm in the SI direction, 4.0 mm
in the LR direction, and 7.9 mm in the AP direction is
needed to cover the target for multiple breath-hold
treatment.
The detail target motion data in both free breathing
and breath-hold scenarios are listed in the Table 1.Probability density functions
The probability distribution functions of the target mo-
tion in free breathing (pdfFB) and breath-hold (pdfBH)
treatment describe the probability of the target at each
position in the entire motion excursion. Figure 2.D
shows the corresponding pdfFB for one of the patients
(Patient5). For the patient daily setup variations, both
pdfSetupFB and pdfSetupBH were generated by using the
Gaussian distributions.Table 2 Comparison of the delivered dose to CTV and organs
techniques: convolution with the probability density function
CTV
V45 V42.75
Mean± SD (%) Mean± SD
Static plan IMRTFB 99.7 ± 0.5 100.0 ± 0.1
IMRTIGBH 99.7 ± 0.6 100.0 ± 0.0
p value 0.96 0.76
Convoluted plan IMRTFB 99.7 ± 0.3 100.0 ± 0.1
IMRTIGBH 99.8 ± 0.4 100.0 ± 0.0
p value 0.78 0.33
N1* for dose to the organs at risk, the free breathing plans were used as the refere
convoluted free breathing plans were used as the reference in the comparison (conDose comparison for the free breathing and breath-hold
treatments
The PTVFB margin for free breathing treatment planning
was calculated to be 22.0, 5.9 and 14.5 mm in the SI, LR
and AP direction, respectively. For the image-guided
breath-hold treatment, a 3.0-mm setup margin was used
to account for the residual error introduced by the online
correction strategy. The internal margin (MBH) was used
to cover the residual target motion for multiple breath-
hold periods. The overall margins for PTVIGBH were
10.2 mm in the SI direction, 5.0 mm in the LR direction
and 8.5 mm in the AP direction. The comparison was per-
formed on 6 randomly selected patients. Table 2 lists the
comparison of the target coverage and the dose to organs
at risks for the original static plans and motion convoluted
plans between free breathing and breath-hold treatment.
All plans were similar in the target coverage with no
significant statistic difference. The p values were 0.96
(for PTV V45, Vx means the percent volume that
received x Gy) and 0.76 (for PTV V42.75) for static plans,
and 0.78 (for V45) and 0.33 (for PTV V42.75) for convo-
luted plans. As for the critical structures, the IMRTFB
was chose as the reference in the comparison of liver
V30 and kidneys V15. Static IMRTIGBH plans had lower
dose to the liver compared to static IMRTFB (p = 0.01),
but no significant difference was found in the kidney
dose. However, after convolution, IMRTIGBH showed
better kidneys sparing (p< 0.01) but similar dose to the
liver (p = 0.08). The dose distributions in the transverse,
sagittal and coronal planes of one patient in the two sce-
narios are shown in Figure 3.The possibility of dose escalation
IMRTIGBH plans with 54 Gy target dose were generated
and compared with the original IMRTFB. As shown in
Table 3, both plans are convolved with the relative pdfs
stated previously. The results show comparable target
coverage and similar doses to liver, left kidney and spinalat risk for free breathing and breath-hold treatment
s
Liver L kidney R kidney
V30 V15 V15
(%) Mean± SD (%) Mean± SD (%) Mean± SD (%)
N1* N1* N1*
−5.6 ± 4.7 −6.0 ± 8.8 −5.4 ± 7.9
0.01 0.09 0.09
N2* N2* N2*
−3.8 ± 5.4 −14.8 ± 9.9 −11.0 ± 7.7
0.08 <0.01 <0.01
nce in the comparison (static plan). N2* for dose to the organs at risk, the
volved plan).
Figure 3 The dose distributions of one patient in free breath mode without (A) and with (B) convolving setup error and target motion
and in combining ABC and online IGRT without (C) and with (D) convolving residual target motion.
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IMRTIGBH.
Discussion
In this study, we investigated the dosimetric benefit of
combining image guidance and breath-hold techniqueTable 3 Comparison of the dose to target and organs at risk




Mean± SD Mean± SD Mean± S
IMRTFB (45 Gy) 95.5 ± 1.4% 98.8 ± 1.1% 30.3 ± 10.
IMRTIGBH(54 Gy) 96.0 ± 0.7% 98.8 ± 0.8% 31.0 ± 8.7for gastric cancer radiotherapy. We applied the convolu-
tion method in calculation of the actual delivered dose.
And based on the results we also showed the feasibility
of dose escalation from 45 Gy to 54 Gy with the image-
guided breath-hold technique while keeping the dose to
the organs at risk at the same level.for free breathing and breath-hold treatment techniques:
nd 54 Gy, respectively
Left kidney Right kidney Spinal cord
V15 V15 Max Dose (Gy)
D Mean± SD Mean± SD
0% 47.5 ± 5.4% 40.2 ± 7.2% 41.6 ± 3.6%
% 47.2 ± 7.6% 34.1 ± 16.3% 43.4 ± 1.0%
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IMRT techniques offer better normal tissue sparing.
Henning GT et al. [13]. reported an improved outcome
associated with four or more radiation fields. Soyfer
et al. [14]. reported that the complex 3DCRT techni-
ques improved PTV coverage and lowered the doses to
the kidneys and spinal cord. Therefore, the IMRT was
used in this study to achieve conformal dose distribu-
tion to the target.
Setup errors and tumor motions are the two main fac-
tors in designing CTV to PTV margins for gastric can-
cer radiotherapy. For setup errors, we found that the
mean and standard deviation was 0.0 ± 1.8 mm in LR,
1.2 ± 3.4 mm in SI and −1.4 ± 3.1 mm in AP direction,
which were considered to follow the Gaussian distribu-
tion. Although our data was derived from the fluoro-
scopic imaging on the simulator, it represented the
patient setup error because the same therapists posi-
tioned the patients on both the simulator and the actual
treatment machines. However, the setup accuracy can be
greatly improved with the online correction strategy
[15]. Therefore, a 3 mm residual setup error after online
image guided was applied for our study.
The target motion presents a challenge in radiotherapy
treatment delivery. Motion degrades the reproducibility
of the patient anatomic structures between the daily
treatment and the initial CT acquisition, and can cause
the dose to the tumor and normal organs differ from the
original treatment plan. Our results showed a large mar-
gin was required for compensating the setup uncertain-
ties and target motion in free breathing treatment. Large
margins hinder the normal tissue sparing and target
dose escalation.
The ABC technique has been widely used to reduce
the respiratory induced organ motion. Wong et al.
reported that the intra-fraction reproducibility of ABC
was about 3 mm [8]. However, ABC can not eliminate
the residual organ motion as well as the intra- and inter-
fraction reproducibility uncertainties [16]. In our study,
we evaluated the target motion within one ABC breath
hold and the overall target motion between different
breath-holds because each treatment fraction required
several breath hold. We found the residual target motion
were 3.7 mm, 1.6 mm and 2.8 mm in the SI, LR and AP
directions, respectively. It is evident that it is possibility
to reduce the margin in gastric cancer treatment using
the breath hold technique.
Combining the daily image guidance and the breath
hold technique can reduce the margin to 5–10 mm.
Comparison of the static IMRTFB and IMRTIGBH plans
demonstrated that the liver received lower dose in
IMRTIGBH (p = 0.01) while the target coverage remained
the same (p> 0.05). Although no significant difference
was found in kidneys (p = 0.09), the doses in IMRTIGBHwere slightly lower in some cases. The reason was that
the margin in the LR direction for both FB and IGBH
was about the same with a range of 5 to 7 mm. And
compared to AP and SI directions, the margin in the LR
direction had the prominent effect in the dose to the
kidneys because of the anatomy positions of the kidneys.
The margin in the AP direction determines how much
the PTV overlaps with the liver, therefore lower dose is
found in the IMRTIGBH.
Organ motion may lead to erroneous prediction of
the actual delivered dose to the patient if the treatment
plan is designed based on the static planning CT
images. Although there are some limitations, the con-
volution method has been proposed to evaluate the
changes in dose distributions during the treatment [17].
We incorporated the setup error and the free breathing
target motion in IMRTFB. For the breath-hold plans,
we assumed that the residual error from the online
correction follow the Gaussian distributions. We found
that both FB and IGBH had adequate target coverage.
However, as for the liver and kidneys, doses were simi-
lar to or lower than the static plans (p< 0.01 for kid-
neys and p = 0.08 for liver), which imply that the actual
kidneys (liver) sparing were better than (similar to) the
planned one.
The ultimate goal of our investigation was to evaluate
the possible dose escalation with the image guidance
and ABC. Our study suggested that a significant dosi-
metric benefit could be achieved by combining the
IMRT, image-guidance and breath-hold techniques in
the treatment delivery. As the result, it is possible to es-
calate the target dose from 45 Gy to 54 Gy while keeping
the critical organs under their dose tolerance. In other
word, a better OAR sparing will be obtained if using the
IGRT and ABC in a 45 Gy prescription. This will be a
potential benefit to those patients with kidneys disease.
This study is purpose on the dosimetric benefit on com-
bining the IGRT and ABC techniques in the gastric can-
cer. Although the dose escalation in gastric radiotherapy
is needed further verification, it is beyond the purpose of
this dosimetric study.Conclusion
The gastric cancer radiotherapy requires a large margin
to account for the setup error and organ motion in the
free breathing treatment. The ABC technique can be
used to reduce the gastric target motion, and further
dosimetric benefit can be achieved by combining breath-
hold and IGRT techniques in the adjuvant gastric cancer
radiotherapy. It is feasible to escalate the target dose if
the online correction strategy is implemented along with
the breath-hold technique. The clinical implication and
outcome needs further study.
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